Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy
Primary Purpose
Bladder Cancer
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Ensure Plus®
Multivitamin
Sponsored by
About this trial
This is an interventional prevention trial for Bladder Cancer focused on measuring radical cystectomy, urinary diversion, nutrition, oral supplementation, enteral nutrition
Eligibility Criteria
Inclusion Criteria:
- all patients eligible for elective radical cystectomy for bladder cancer at the sponsoring institution
Exclusion Criteria:
- inability to tolerate oral supplementation
Sites / Locations
- Vanderbilt University Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Nutrition Intervention
Control
Arm Description
Ensure Plus®, consumed orally twice daily for 2 weeks before and 4 weeks after surgery
Over the counter daily multivitamin for 2 weeks before and 4 weeks after surgery
Outcomes
Primary Outcome Measures
Hospital-free days (HFDs)
The study is powered to detect a difference in the number of HFDs over a 30 day period between intervention and control groups
Secondary Outcome Measures
Serum markers
The investigators will compare serum levels of albumin, prealbumin, transferrin and retinol binding protein and C-reactive protein between groups
Body composition
The investigators will measure difference in lean body mass and fat mass between intervention and controls using whole body dual energy X-ray absorptiometry (DEXA) scan
Tolerability / compliance
The investigators will assess the patients' ability to tolerate and comply with the nutrition intervention
Complications
The investigators will compare the difference in rate, type and severity of post-operative complications between groups
Length of stay
The investigators will compare the length of stay following surgery between the two groups
Readmission rate
The investigators will compare the rate of readmissions over the 30 day postoperative period between intervention and control
Mortality
The investigators will compare overall survival between groups over the 30 day postoperative period
Calories
The investigators will compare caloric and nutrient intake between groups using comprehensive dietary assessment tools
Full Information
NCT ID
NCT02050451
First Posted
January 28, 2014
Last Updated
March 27, 2017
Sponsor
Vanderbilt University
Collaborators
University of Oklahoma
1. Study Identification
Unique Protocol Identification Number
NCT02050451
Brief Title
Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy
Official Title
A Pilot Study of Perioperative Oral Nutrition Supplementation to Improve Nutritional Status, Post-operative Complications, Length of Stay and Readmission Rates in Patients Undergoing Radical Cystectomy
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Completed
Study Start Date
March 2014 (Actual)
Primary Completion Date
December 2016 (Actual)
Study Completion Date
March 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University
Collaborators
University of Oklahoma
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The current study is designed to assess the impact of an enriched oral nutritional shake (Ensure Plus®) to improve the nutritional status and patient outcome after surgery to remove a cancerous bladder (radical cystectomy). Radical cystectomy with urinary diversion using a segment of intestine is the standard of care for invasive bladder cancer. This operation has a high complication rate and several studies have shown that this may be directly related to poor nutrition.
The investigators believe that patients who consume an enriched nutritional shake before and after surgery will improve their nutrition status and experience fewer complications, shorter length of stay and less readmissions compared to those who do not.
Patients who are scheduled to undergo elective radical cystectomy will be eligible for enrollment. Once enrolled, they will be randomly assigned to one of two groups. One group will be offered Ensure Plus® twice daily for 2 weeks before and 4 weeks after their surgery and the other will be offered a daily over-the-counter multivitamin for the same period of time. The investigators will follow both groups for up to 30 days after their surgery and compare clinical outcomes such as: complication rates, length of stay, readmission rates and mortality as well as measure serum markers of nutrition status and assess changes in body composition.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bladder Cancer
Keywords
radical cystectomy, urinary diversion, nutrition, oral supplementation, enteral nutrition
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Nutrition Intervention
Arm Type
Experimental
Arm Description
Ensure Plus®, consumed orally twice daily for 2 weeks before and 4 weeks after surgery
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Over the counter daily multivitamin for 2 weeks before and 4 weeks after surgery
Intervention Type
Dietary Supplement
Intervention Name(s)
Ensure Plus®
Other Intervention Name(s)
Ensure®
Intervention Type
Dietary Supplement
Intervention Name(s)
Multivitamin
Primary Outcome Measure Information:
Title
Hospital-free days (HFDs)
Description
The study is powered to detect a difference in the number of HFDs over a 30 day period between intervention and control groups
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Serum markers
Description
The investigators will compare serum levels of albumin, prealbumin, transferrin and retinol binding protein and C-reactive protein between groups
Time Frame
30 days
Title
Body composition
Description
The investigators will measure difference in lean body mass and fat mass between intervention and controls using whole body dual energy X-ray absorptiometry (DEXA) scan
Time Frame
30 days
Title
Tolerability / compliance
Description
The investigators will assess the patients' ability to tolerate and comply with the nutrition intervention
Time Frame
30 days
Title
Complications
Description
The investigators will compare the difference in rate, type and severity of post-operative complications between groups
Time Frame
30 days
Title
Length of stay
Description
The investigators will compare the length of stay following surgery between the two groups
Time Frame
30 days
Title
Readmission rate
Description
The investigators will compare the rate of readmissions over the 30 day postoperative period between intervention and control
Time Frame
30 days
Title
Mortality
Description
The investigators will compare overall survival between groups over the 30 day postoperative period
Time Frame
30 days
Title
Calories
Description
The investigators will compare caloric and nutrient intake between groups using comprehensive dietary assessment tools
Time Frame
30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
all patients eligible for elective radical cystectomy for bladder cancer at the sponsoring institution
Exclusion Criteria:
inability to tolerate oral supplementation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chad R Ritch, MD
Organizational Affiliation
Department of Urologic Surgery, Vanderbilt University Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Michael S Cookson, MD
Organizational Affiliation
Department of Urology, University of Oklahoma Medical Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Heidi J Silver, PhD, RD
Organizational Affiliation
Vanderbilt Center for Human Nutrition
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Peter E Clark, MD
Organizational Affiliation
Department of Urologic Surgery, Vanderbilt University Medical Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Sam S Chang, MD
Organizational Affiliation
Department of Urologic Surgery, Vanderbilt University Medical Center
Official's Role
Study Director
Facility Information:
Facility Name
Vanderbilt University Medical Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
21074802
Citation
Gregg JR, Cookson MS, Phillips S, Salem S, Chang SS, Clark PE, Davis R, Stimson CJ Jr, Aghazadeh M, Smith JA Jr, Barocas DA. Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. J Urol. 2011 Jan;185(1):90-6. doi: 10.1016/j.juro.2010.09.021. Epub 2010 Nov 12.
Results Reference
background
PubMed Identifier
20723939
Citation
Stimson CJ, Chang SS, Barocas DA, Humphrey JE, Patel SG, Clark PE, Smith JA Jr, Cookson MS. Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol. 2010 Oct;184(4):1296-300. doi: 10.1016/j.juro.2010.06.007. Epub 2010 Aug 17.
Results Reference
background
PubMed Identifier
21788035
Citation
Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Phillips SE, Chang SS, Penson DF, Clark PE, Smith JA Jr, Cookson MS. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol. 2011 Sep;186(3):829-34. doi: 10.1016/j.juro.2011.04.089. Epub 2011 Jul 23.
Results Reference
background
Learn more about this trial
Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy
We'll reach out to this number within 24 hrs